Chicago Consensus Conference peritoneal mesothelioma management pathway

H&P: history and physical examination; CT: computed tomography; C/A/P: chest/abdomen/pelvis; MRI: magnetic resonance imaging; A/P: abdomen/pelvis; CA 125: cancer antigen 125; Ki-67: histologic proliferation index; BAP1: BRCA1-associated protein 1 cancer syndrome; CRS: cytoreductive surgery; IPCT: intraperitoneal chemotherapy; ECOG: Eastern Cooperative Oncology Group; EPIC: early postoperative intraperitoneal chemotherapy; NIPC: neoadjuvant intraperitoneal chemotherapy; PCI: peritoneal carcinomatosis index.
* Higher risk for progression if microinvasive features are present.